# Novo Nordisk invests €2.1B in Chartres production site expansion

Novo Nordisk announced an investment of more than 16 billion Danish kroner (€2.1 billion) to expand its production site in Chartres, France, adding aseptic and finished production processes and a quality control lab, creating over 500 jobs.

- Type: Expansion
- Announced: 2023-11-23
- Where: Chartres, France, France
- Value: $2.29B (2.10B EUR)
- Jobs: 500
- Starts operating: 2026
- Status: announced
- Products: GLP-1 products, medicines for serious chronic diseases
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2023/11/23/2785347/0/en/novo-nordisk-invests-more-than-16-billion-danish-kroner-in-expansion-of-production-facilities-in-chartres-france.html), 2023-11-23: "This significant investment announced today confirms the importance of our French manufacturing site, one of our strategic production sites, as a cornerstone of the growth we are experiencing as a company."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.